BIOMAT Database Logo BIOMAT Database Logo

Central inhibition of vasomotor activity by guanethidine. 1962

Y KANEKO, and J W McCUBBIN, and I H PAGE

UI MeSH Term Description Entries
D006145 Guanethidine An antihypertensive agent that acts by inhibiting selectively transmission in post-ganglionic adrenergic nerves. It is believed to act mainly by preventing the release of norepinephrine at nerve endings and causes depletion of norepinephrine in peripheral sympathetic nerve terminals as well as in tissues. ((2-Hexahydro-1(2H)-azocinyl)ethyl)guanidine,Guanethidine Monosulfate,Guanethidine Sulfate,Guanethidine Sulfate (1:1),Guanethidine Sulfate (1:2),Guanethidine Sulfate (2:1),Guanethidine Sulfate (2:1), 14C-Labeled,Ismelin,Isobarin,Octadine,Oktadin,Monosulfate, Guanethidine,Sulfate, Guanethidine
D000578 Amidines Derivatives of oxoacids RnE(
D000959 Antihypertensive Agents Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. Anti-Hypertensive,Anti-Hypertensive Agent,Anti-Hypertensive Drug,Antihypertensive,Antihypertensive Agent,Antihypertensive Drug,Anti-Hypertensive Agents,Anti-Hypertensive Drugs,Anti-Hypertensives,Antihypertensive Drugs,Antihypertensives,Agent, Anti-Hypertensive,Agent, Antihypertensive,Agents, Anti-Hypertensive,Agents, Antihypertensive,Anti Hypertensive,Anti Hypertensive Agent,Anti Hypertensive Agents,Anti Hypertensive Drug,Anti Hypertensive Drugs,Anti Hypertensives,Drug, Anti-Hypertensive,Drug, Antihypertensive,Drugs, Anti-Hypertensive,Drugs, Antihypertensive
D014666 Vasomotor System The neural systems which act on VASCULAR SMOOTH MUSCLE to control blood vessel diameter. The major neural control is through the sympathetic nervous system. System, Vasomotor,Systems, Vasomotor,Vasomotor Systems

Related Publications

Y KANEKO, and J W McCUBBIN, and I H PAGE
Inhibition of central vasomotor tone by imipramine.
March 1967, Japanese journal of pharmacology,
Y KANEKO, and J W McCUBBIN, and I H PAGE
Central vasomotor stimulation by angiotensin.
August 1970, Clinical science,
Y KANEKO, and J W McCUBBIN, and I H PAGE
Inhibition of vasomotor reflexes by ajmaline.
July 1954, The Indian journal of medical research,
Y KANEKO, and J W McCUBBIN, and I H PAGE
Inhibition of S-adenosyl methionine decarboxylase by guanethidine.
January 1980, Biochemical pharmacology,
Y KANEKO, and J W McCUBBIN, and I H PAGE
Inhibition by guanethidine of chemoreceptor reflex-induced vasodilatation.
December 1977, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
Y KANEKO, and J W McCUBBIN, and I H PAGE
[Central control of thirst caused by vasomotor changes].
February 1973, Bollettino della Societa italiana di biologia sperimentale,
Y KANEKO, and J W McCUBBIN, and I H PAGE
SYMPATHOMIMETIC ACTIVITY OF GUANETHIDINE.
August 1963, The Journal of pharmacy and pharmacology,
Y KANEKO, and J W McCUBBIN, and I H PAGE
Do ganglion-blocking agents and reserpine affect central vasomotor activity?
November 1958, Circulation research,
Y KANEKO, and J W McCUBBIN, and I H PAGE
Central action of angiotensin and hypertension--increased central vasomotor outflow by angiotensin.
June 1972, Japanese circulation journal,
Y KANEKO, and J W McCUBBIN, and I H PAGE
[Inhibition of the cardiotonic action of auabain by reserpine and guanethidine].
January 1963, Comptes rendus des seances de la Societe de biologie et de ses filiales,
Copied contents to your clipboard!